ALISHA SMITH: Open Payments
NPI 1487900668 · HARRAH, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 50 payments from 10 companies in 2025. Trend: 2023 $538 · 2024 $406 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $225 |
| AstraZeneca Pharmaceuticals LP | 9 | $180 |
| Novo Nordisk Inc | 11 | $169 |
| Lilly USA, LLC | 7 | $128 |
| Exact Sciences Corporation | 3 | $46 |
| Amgen Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $29 |
| bioMerieux Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: VRAYLAR, AIRSUPRA, MOUNJARO, Saxenda, UBRELVY, JARDIANCE, FARXIGA, Cologuard Collection Kit.
Industry payments across OK — which companies pay providers there.
